Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Inogen Inc Director's Dealing 2015

Sep 19, 2015

33625_dirs_2015-09-18_750356d4-7cd0-426c-8b74-f49afc9b327c.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Inogen Inc (INGN)
CIK: 0001294133
Period of Report: 2015-09-16

Reporting Person: Myers Byron (Vice President, Marketing)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2015-09-16 Common Stock M 400 $0.60 Acquired 36732 Direct
2015-09-16 Common Stock M 1300 $0.60 Acquired 38032 Direct
2015-09-16 Common Stock S 400 $55.00 Disposed 37632 Direct
2015-09-16 Common Stock S 1300 $55.00 Disposed 36332 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2015-09-16 Stock Option (right to buy) $0.60 M 400 Disposed 2019-02-10 Common Stock (400) Direct
2015-09-16 Stock Option (right to buy) $0.60 M 1300 Disposed 2020-02-24 Common Stock (1300) Direct

Footnotes

F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 15, 2015.

F2: Subject to the reporting person's continued service, sixty percent (60%) of the shares subject to the option vested and became exercisable on the vesting commencement date, and thereafter, one thirtieth (1/30th) of the remaining shares subject to the option vested each month on the same day as the vesting commencement date, such that the shares subject to the option became fully vested and exercisable on the thirty (30) month anniversary of the vesting commencement date. The vesting commencement date for this option is February 24, 2010. This option is fully vested as of August 24, 2012.